PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 10, p. 1, doi. 10.1002/ctm2.1062
- By:
- Publication type:
- Article
Works by Liu, Zhengchuang
Results: 8
1
2
Genomic and Transcriptional Profiling of Chinese Melanoma Patients Enhanced Potentially Druggable Targets: A Multicenter Study.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 283, doi. 10.3390/cancers15010283
- By:
- Publication type:
- Article
3
Clinical relevance and druggability of sole reciprocal kinase fusions: A large‐scale study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 17, p. 1, doi. 10.1002/cam4.70191
- By:
- Publication type:
- Article
4
Prevalence and spectrum of cancer predisposition germline mutations in young patients with the common late‐onset cancers.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18394, doi. 10.1002/cam4.6445
- By:
- Publication type:
- Article
5
Identification of MET fusions in solid tumors: A multicenter, large scale study in China.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 6, p. 1259, doi. 10.1002/ijc.34361
- By:
- Publication type:
- Article
6
Superiority of targeted RNA sequencing for fusion detection and subtype diagnosis in Chinese sarcoma patients: a multicenter study.
- Published in:
- 2025
- By:
- Publication type:
- Letter
7
Novel insights into molecular patterns of ROS1 fusions in a large Chinese NSCLC cohort: a multicenter study.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 10, p. 2200, doi. 10.1002/1878-0261.13509
- By:
- Publication type:
- Article
8
Molecular characterization of genomic breakpoints of ALK rearrangements in non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 5, p. 765, doi. 10.1002/1878-0261.13348
- By:
- Publication type:
- Article